| __timestamp | PTC Therapeutics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 31354781 |
| Thursday, January 1, 2015 | 121816000 | 43445817 |
| Friday, January 1, 2016 | 117633000 | 66489820 |
| Sunday, January 1, 2017 | 117456000 | 96886134 |
| Monday, January 1, 2018 | 171984000 | 153793000 |
| Tuesday, January 1, 2019 | 257452000 | 148369000 |
| Wednesday, January 1, 2020 | 477643000 | 151934000 |
| Friday, January 1, 2021 | 540684000 | 198532000 |
| Saturday, January 1, 2022 | 651496000 | 112128000 |
| Sunday, January 1, 2023 | 666563000 | 76192000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and PTC Therapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, PTC Therapeutics has consistently outpaced TG Therapeutics, with its R&D expenses growing by over 730%, peaking in 2023. In contrast, TG Therapeutics saw a more modest increase of approximately 143% during the same period. Notably, PTC Therapeutics' R&D spending surged significantly in 2020, marking a pivotal year in its innovation journey. This trend underscores PTC's aggressive pursuit of breakthroughs, while TG Therapeutics maintains a steady, albeit slower, pace. As the biotech sector continues to expand, these spending patterns offer valuable insights into each company's strategic priorities and potential future breakthroughs.
GSK plc vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
R&D Insights: How Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
Research and Development Investment: Halozyme Therapeutics, Inc. vs PTC Therapeutics, Inc.
TG Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
TG Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and PTC Therapeutics, Inc.
Viking Therapeutics, Inc. vs PTC Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated